Minerva Medica 2021 Sep 03

DOI: 10.23736/S0026-4806.21.07716-8

language: English

BRD7 increases resistance to EGFR tyrosine kinase inhibitor (EGFR-TKI) in non-small cell lung cancer

Haiping ZHANG ¹, Li ZHANG ², Jianfang XU ¹ ✉

¹ Department of Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China; ² Department of Respiratory and Critical Care Medicine, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China

PDF

top of page

YOUR ACCOUNT

YOUR ORDERS

SHOPPING BASKET

HOW TO ORDER

YOUR SUBSCRIPTIONS

YOUR ARTICLES

YOUR EBOOKS

COUPON

ACCESSIBILITY

Minerva Medica 2021 Sep 03

BRD7 increases resistance to EGFR tyrosine kinase inhibitor (EGFR-TKI) in non-small cell lung cancer

Publication History

Cite this article as

Corresponding author e-mail

Share